American Oriental Bioengineering to Participate in the 2009 UBS Greater China Conference

* Reuters is not responsible for the content in this press release.

Mon Jan 12, 2009 8:30am EST 

American Oriental Bioengineering to Participate in the 2009 UBS Greater China
Conference

NEW YORK, Jan. 12 /PRNewswire-Asia-FirstCall/ -- American Oriental
Bioengineering, Inc. (NYSE: AOB) ("AOBO" or "the Company"), a leading
marketer,
distributor and manufacturer of pharmaceutical and healthcare products in
China, today announced that the Company will attend and undertake one-on-one
meetings at the 2009 UBS Greater China Conference, held at the Pudong
Shangri-La hotel in Shanghai.  Management is currently scheduled to meet with
institutional investors on January 12 and 13, 2009.
    For more details on the conference, please contact your UBS institutional
sales representative.
    About American Oriental Bioengineering Inc.
    American Oriental Bioengineering, Inc., is a pharmaceutical company
dedicated to improving health through the development, manufacture and
commercialization of a broad range of prescription and over the counter
products in China.
SOURCE  American Oriental Bioengineering Inc.

Ashley Ammon of Integrated Corporate Relations, +1-203-682-8200, for AOB
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.